Health Affairs June 24, 2024
The Centers for Medicare and Medicaid Services (CMS) hosted listening sessions for stakeholders to offer feedback on the first ten drugs selected for the Medicare Drug Price Negotiation Program (DPNP) in October and November 2023. Gathering and incorporating patient perspectives should be an important step in health care policy, and CMS created a unique opportunity by engaging in these sessions, which were not required under the Inflation Reduction Act.
However, the meeting structure prevented CMS from meaningfully engaging with patients and clinicians. Participants reported feeling underprepared for the listening sessions and that it was difficult to participate or craft testimony to address CMS needs meaningfully. The structure of the sessions resulted in CMS receiving incomplete information or data not pertinent...
Today's Sponsors
Today's Sponsor